Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Cutting Edge: Lymphomyeloid-Primed Progenitor Cell Fates Are Controlled by the Transcription Factor Tal1.

de Pooter RF, Dias S, Chowdhury M, Bartom ET, Okoreeh MK, Sigvardsson M, Kee BL.

J Immunol. 2019 May 15;202(10):2837-2842. doi: 10.4049/jimmunol.1801220. Epub 2019 Apr 8.

PMID:
30962294
2.

Transcription factor ID2 prevents E proteins from enforcing a naïve T lymphocyte gene program during NK cell development.

Zook EC, Li ZY, Xu Y, de Pooter RF, Verykokakis M, Beaulieu A, Lasorella A, Maienschein-Cline M, Sun JC, Sigvardsson M, Kee BL.

Sci Immunol. 2018 Apr 27;3(22). pii: eaao2139. doi: 10.1126/sciimmunol.aao2139.

3.

Murine thymic NK cells are distinct from ILC1s and have unique transcription factor requirements.

Gabrielli S, Sun M, Bell A, Zook EC, de Pooter RF, Zamai L, Kee BL.

Eur J Immunol. 2017 May;47(5):800-805. doi: 10.1002/eji.201646871. Epub 2017 Apr 13.

4.

Correction: Repression of Ccr9 transcription in mouse T lymphocyte progenitors by the notch signaling pathway.

Krishnamoorthy V, Carr T, de Pooter RF, Emanuelle AO, Gounari F, Kee BL.

J Immunol. 2015 Jun 15;194(12):6191. doi: 10.4049/jimmunol.1500914. No abstract available.

5.

Repression of Ccr9 transcription in mouse T lymphocyte progenitors by the Notch signaling pathway.

Krishnamoorthy V, Carr T, de Pooter RF, Emanuelle AO, Gounari F, Kee BL.

J Immunol. 2015 Apr 1;194(7):3191-200. doi: 10.4049/jimmunol.1402443. Epub 2015 Feb 20. Erratum in: J Immunol. 2015 Jun 15;194(12):6191. Akinola, Emmanuel Olumide [Corrected to Emanuelle, Akinola Olumide].

6.

E proteins and the regulation of early lymphocyte development.

de Pooter RF, Kee BL.

Immunol Rev. 2010 Nov;238(1):93-109. doi: 10.1111/j.1600-065X.2010.00957.x. Review.

7.

Beyond tumor necrosis factor receptor: TRADD signaling in toll-like receptors.

Chen NJ, Chio II, Lin WJ, Duncan G, Chau H, Katz D, Huang HL, Pike KA, Hao Z, Su YW, Yamamoto K, de Pooter RF, Zúñiga-Pflücker JC, Wakeham A, Yeh WC, Mak TW.

Proc Natl Acad Sci U S A. 2008 Aug 26;105(34):12429-34. doi: 10.1073/pnas.0806585105. Epub 2008 Aug 21.

8.

Generation of immunocompetent T cells from embryonic stem cells.

de Pooter RF, Zúñiga-Pflücker JC.

Methods Mol Biol. 2007;380:73-81. Review.

PMID:
17876088
9.

In vitro generation of T lymphocytes from embryonic stem cells.

de Pooter RF, Schmitt TM, Zúñiga-Pflücker JC.

Methods Mol Biol. 2006;330:113-21.

PMID:
16846020
10.

Notch signaling requires GATA-2 to inhibit myelopoiesis from embryonic stem cells and primary hemopoietic progenitors.

de Pooter RF, Schmitt TM, de la Pompa JL, Fujiwara Y, Orkin SH, Zúñiga-Pflücker JC.

J Immunol. 2006 May 1;176(9):5267-75.

11.

In vitro generation of lymphocytes from embryonic stem cells.

de Pooter RF, Cho SK, Zúñiga-Pflücker JC.

Methods Mol Biol. 2005;290:135-47.

PMID:
15361660
12.

Induction of T cell development and establishment of T cell competence from embryonic stem cells differentiated in vitro.

Schmitt TM, de Pooter RF, Gronski MA, Cho SK, Ohashi PS, Zúñiga-Pflücker JC.

Nat Immunol. 2004 Apr;5(4):410-7. Epub 2004 Mar 21.

13.

In vitro generation of T lymphocytes from embryonic stem cell-derived prehematopoietic progenitors.

de Pooter RF, Cho SK, Carlyle JR, Zúñiga-Pflücker JC.

Blood. 2003 Sep 1;102(5):1649-53. Epub 2003 May 8.

PMID:
12738664

Supplemental Content

Loading ...
Support Center